Cancer-associated fibroblasts-derived exosomes in colorectal cancer progression: Mechanism and therapeutic opportunities

Key Points

• Cancer-associated fibroblasts' exosomes contribute to colorectal cancer progression by influencing the tumor microenvironment.
• Increased levels of specific exosomal markers correlate with aggressive tumor characteristics in colorectal cancer.
• Assessment of exosomal activity provides insights into potential therapeutic strategies targeting cancer-associated fibroblasts.
• Highlights the need for further exploration of exosome-related therapies in colorectal cancer treatment.